Yan Song

Vice President
Yan Song



Ph.D., epidemiology, University of California, Los Angeles; M.S., epidemiology and biostatistics, and M.B.B.S., medicine, Peking University

Summary of Experience

Dr. Song is an epidemiologist with expertise in biostatistics and clinical medicine, which he uses to address a wide array of analytical questions in health care. He has broad experience designing and implementing advanced and innovative real-world data analytic and economic modeling solutions for pharmaceutical clients. Dr. Song conducts research to evaluate and compare the clinical, economic, and humanistic impacts of diseases and treatments across a variety of therapeutic areas. He is experienced in disease areas including oncology, hematology, infectious disease and vaccines, dermatology, rheumatology, endocrinology, and ophthalmology. Dr. Song has provided cross-indication consulting for multiple blockbuster pharmaceutical products as well as novel pipeline agents. In his work, Dr. Song uses data from clinical trials, administrative claims, medical chart reviews, surveys, qualitative interviews, and medical literature. His research has covered many different study types, including disease epidemiology, burden-of-illness, disease treatment and management patterns, comparative effectiveness research, individualized medicine, systematic literature reviews, indirect treatment comparisons, cost-effectiveness analyses, budget impact analyses, analyses of patient-reported outcomes, and preference research such as discrete-choice experiments. Dr. Song’s work has been published in peer-reviewed journals and presented at international conferences on medical and health care research.

Selected Publishing